Is Reishi Immune Randomized Trial safe?

Updated May 2026

Quick Answer

Reishi Immune Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Recognized as pathogen-associated molecular patterns (PAMPs) in the intestine, β-glucans and proteoglycans boost innate immunity and enhance the adaptive immune response to different antigens.

Key Takeaways

  • 01Recognized as pathogen-associated molecular patterns (PAMPs) in the intestine, β-glucans and proteoglycans boost innate immunity and enhance the adaptive immune response to different antigens. [Kirdeeva Yulia (2026)]
  • 02Finally, we will discuss the safety, limitations, and clinical experience associated with the use of medical mushrooms in oncology. [Kirdeeva Yulia (2026)]
  • 03Agaricus bisporus Lentinula edodes Pleurotus ostreatus Pleurotus eryngii Auricularia heimuer Volvariella volvacea Flammulina filiformis Figure 1 First, consumption has increased due to the commercial cultivation of mushrooms. [Kirdeeva Yulia (2026)]
  • 041 2 3 4 5 6 7 8 Agaricus bisporus Pleurotus ostreatus Volvariella volvacea Natural compounds from plants and mushrooms are a source of continuous development for anticancer therapeutics [,,,,]. [Kirdeeva Yulia (2026)]
The current Migaku evidence database contains 2 reusable source documents for Reishi Immune Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Recognized as pathogen-associated molecular patterns (PAMPs) in the intestine, β-glucans and proteoglycans boost innate immunity and enhance the adaptive immune response to different antigens. [Kirdeeva Yulia (2026); evidence level 3] - Finally, we will discuss the safety, limitations, and clinical experience associated with the use of medical mushrooms in oncology. [Kirdeeva Yulia (2026); evidence level 3] - Agaricus bisporus Lentinula edodes Pleurotus ostreatus Pleurotus eryngii Auricularia heimuer Volvariella volvacea Flammulina filiformis Figure 1 First, consumption has increased due to the commercial cultivation of mushrooms. [Kirdeeva Yulia (2026); evidence level 3] - 1 2 3 4 5 6 7 8 Agaricus bisporus Pleurotus ostreatus Volvariella volvacea Natural compounds from plants and mushrooms are a source of continuous development for anticancer therapeutics [,,,,]. [Kirdeeva Yulia (2026); evidence level 3] - Purpose of review Biochemical recurrence of epithelial ovarian cancer (EOC), defined as rising CA-125 levels without clinical or radiologic evidence of disease, is a frequent and challenging scenario. [Berman T (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level
  2. Integrative Oncology for Biochemical Recurrence of Epithelial Ovarian Cancer.